
Journal of Medicinal Chemistry p. 177 - 184 (1992)
Update date:2022-08-03
Topics:
Davis, Peter D.
Hill, Christopher H.
Lawton, Geoffrey
Nixon, John S.
Wilkinson, Sandra E.
et al.
The design and synthesis of a series of novel inhibitors of protein kinase C (PKC) is described.These 2,3-bisarylmaleimides were derived from the structural lead provided by the indolocarbazoles, staurosporine and K252a.Optimum activity required the imide NH, both carbonyl groups, and the olefinic bond of the maleimide ring. 2,3-Bisindolylmaleimides were the most active, and the potency of these was improved by a chloro substituent at the 5-position of one indole ring (compound 28, IC50 0.11 μM).In a series of (phenylindolyl)maleimides, nitro compound 74 was most active (IC50 0.67 μM).Naphthalene 19 and benzothiophene 21 showed greater than 100-fold selectivity for inhibition of PKC over the closely related cAMP-dependent protein kinase (PKA).
View MoreShijiazhuang Haotian Chemical Co., Ltd.
Contact:86-311-85044374
Address:293 Donggang Road
Pengchen New Material Technology Co., Ltd.
Contact:+86-512-63680537
Address:99.6 km of national road 318, Meiyan Community,Pingwang Town, Wujiang District, Suzhou 215225
Airsea(Taizhou) Pharmaceutical Limited(expird)
Contact:+86-576-88057622
Address:Dubei, Duqiao, Linhai, Taizhou, Zhejiang, China Zip: 317016
Zhejiang Chemline International Co., Ltd.
Contact:+86-571-88062298
Address:Hengdian Industry Area, Dongyang, Zhejiang, China
Contact:86-371-63655023
Address:No.85,jinshui road,zhengzhou,China
Doi:10.1002/prac.19983400104
(1998)Doi:10.1246/cl.1998.1123
(1998)Doi:10.1021/ja973881r
(1998)Doi:10.1007/pl00010154
(1998)Doi:10.1021/jo971053a
(1998)Doi:10.1016/j.tet.2017.04.017
(2017)